Table 1 Clinical characteristics and perioperative data
Patient 1 | Patient 2 | |
|---|---|---|
Sex | Female | Female |
Age | 67 | 68 |
Body mass index (kg/m2) | 32.6 | 32.5 |
ASA score | 4E | 3E |
TG grade | III | II |
Preoperative severity assessment | Cardiovascular dysfunction (requiring treatment with dopamine and norepinephrine), hepatic dysfunction (PT-INR 1.68), CT finding (marked local inflammation; gangrenous cholecystitis and pericholecystic abscess) | Palpable tender mass in the right upper abdominal quadrant, duration of complaints; 15 days, CT finding (marked local inflammation; pericholecystic abscess) |
Preoperative risk factors | Dilated cardiomyopathy (ejection fraction 27%), type 2 diabetes mellitus (HbA1c 9.2%), atrial fibrillation (rivaroxaban) | Hyperlipidemia, chronic heart failure |
Operative time (min) | 120 | 147 |
Estimated blood loss (ml) | 10 | 5 |
Postoperative hospital stay (days) | 12 | 5 |
Postoperative morbidity | None | None |
Pathological diagnosis | Gangrenous cholecystitis | Acute-on-chronic cholecystitis |